Chapter 11. Drug Effects in Patients with Mitochondrial Diseases
- James A. Dykens2,
- Yvonne Will3
Published Online: 22 JAN 2008
DOI: 10.1002/9780470372531.ch11
Copyright © 2008 John Wiley & Sons, Inc.
Book Title

Drug-Induced Mitochondrial Dysfunction
Additional Information
How to Cite
Schon, E. A., Hirano, M. and Dimauro, S. (2008) Drug Effects in Patients with Mitochondrial Diseases, in Drug-Induced Mitochondrial Dysfunction (eds J. A. Dykens and Y. Will), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9780470372531.ch11
Editor Information
- 2
Pfizer, Inc., Sandwich, UK
- 3
Pfizer, Inc., Groton, Connecticut, USA
Publication History
- Published Online: 22 JAN 2008
- Published Print: 14 SEP 2008
ISBN Information
Print ISBN: 9780470111314
Online ISBN: 9780470372531
- Summary
- Chapter
- References
Keywords:
- mitochondrial diseases and drug toxicity;
- human nDNA pathogenic mutations in respiratory chain dysfunction;
- dichloroacetate (DCA) treatment in MELAS
Summary
This chapter contains sections titled:
Mitochondrial diseases: a brief overview
Drug toxicity in mitochondrial diseases: direct effects
Drug toxicity in mitochondrial diseases: indirect effects
Drug toxicity in mitochondrial diseases: hypothetical effects
Potential therapies
Conclusions
References
